nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2B—Etoposide—uterine cancer	0.501	0.624	CbGbCtD
Dexrazoxane—TOP2A—Epirubicin—uterine cancer	0.13	0.163	CbGbCtD
Dexrazoxane—TOP2A—Etoposide—uterine cancer	0.102	0.127	CbGbCtD
Dexrazoxane—TOP2A—Doxorubicin—uterine cancer	0.0693	0.0865	CbGbCtD
Dexrazoxane—TOP2B—myometrium—uterine cancer	0.00461	0.0807	CbGeAlD
Dexrazoxane—TOP2B—uterine cervix—uterine cancer	0.00358	0.0628	CbGeAlD
Dexrazoxane—TOP2B—smooth muscle tissue—uterine cancer	0.00348	0.061	CbGeAlD
Dexrazoxane—TOP2B—decidua—uterine cancer	0.00342	0.0598	CbGeAlD
Dexrazoxane—TOP2A—myometrium—uterine cancer	0.00339	0.0593	CbGeAlD
Dexrazoxane—TOP2B—renal system—uterine cancer	0.00335	0.0587	CbGeAlD
Dexrazoxane—TOP2B—endometrium—uterine cancer	0.00324	0.0568	CbGeAlD
Dexrazoxane—TOP2B—mammalian vulva—uterine cancer	0.00314	0.0549	CbGeAlD
Dexrazoxane—TOP2B—uterus—uterine cancer	0.00299	0.0523	CbGeAlD
Dexrazoxane—TOP2B—female reproductive system—uterine cancer	0.00269	0.047	CbGeAlD
Dexrazoxane—TOP2A—uterine cervix—uterine cancer	0.00264	0.0462	CbGeAlD
Dexrazoxane—TOP2A—decidua—uterine cancer	0.00251	0.044	CbGeAlD
Dexrazoxane—TOP2B—female gonad—uterine cancer	0.00244	0.0428	CbGeAlD
Dexrazoxane—TOP2B—vagina—uterine cancer	0.00243	0.0425	CbGeAlD
Dexrazoxane—TOP2A—endometrium—uterine cancer	0.00238	0.0418	CbGeAlD
Dexrazoxane—TOP2B—Teniposide—Etoposide—uterine cancer	0.00232	0.456	CbGdCrCtD
Dexrazoxane—TOP2A—mammalian vulva—uterine cancer	0.00231	0.0404	CbGeAlD
Dexrazoxane—TOP2A—uterus—uterine cancer	0.0022	0.0385	CbGeAlD
Dexrazoxane—TOP2A—female gonad—uterine cancer	0.0018	0.0315	CbGeAlD
Dexrazoxane—TOP2A—vagina—uterine cancer	0.00179	0.0313	CbGeAlD
Dexrazoxane—TOP2B—lymph node—uterine cancer	0.00157	0.0275	CbGeAlD
Dexrazoxane—TOP2A—lymph node—uterine cancer	0.00116	0.0202	CbGeAlD
Dexrazoxane—TOP2A—Podofilox—Etoposide—uterine cancer	0.000374	0.0737	CbGdCrCtD
Dexrazoxane—TOP2A—Teniposide—Etoposide—uterine cancer	0.000374	0.0737	CbGdCrCtD
Dexrazoxane—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000353	0.00259	CcSEcCtD
Dexrazoxane—Alopecia—Dactinomycin—uterine cancer	0.000352	0.00259	CcSEcCtD
Dexrazoxane—Neoplasm malignant—Doxorubicin—uterine cancer	0.000349	0.00257	CcSEcCtD
Dexrazoxane—Decreased appetite—Progesterone—uterine cancer	0.000348	0.00256	CcSEcCtD
Dexrazoxane—Erythema—Dactinomycin—uterine cancer	0.000347	0.00255	CcSEcCtD
Dexrazoxane—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000346	0.00255	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Progesterone—uterine cancer	0.000346	0.00254	CcSEcCtD
Dexrazoxane—Fatigue—Progesterone—uterine cancer	0.000345	0.00254	CcSEcCtD
Dexrazoxane—Pain—Progesterone—uterine cancer	0.000342	0.00252	CcSEcCtD
Dexrazoxane—Constipation—Progesterone—uterine cancer	0.000342	0.00252	CcSEcCtD
Dexrazoxane—Pancytopenia—Etoposide—uterine cancer	0.000342	0.00252	CcSEcCtD
Dexrazoxane—Extravasation—Doxorubicin—uterine cancer	0.000341	0.00251	CcSEcCtD
Dexrazoxane—Blood bilirubin increased—Epirubicin—uterine cancer	0.00034	0.0025	CcSEcCtD
Dexrazoxane—Creatinine increased—Epirubicin—uterine cancer	0.000338	0.00249	CcSEcCtD
Dexrazoxane—Neutropenia—Etoposide—uterine cancer	0.000337	0.00248	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000331	0.00243	CcSEcCtD
Dexrazoxane—Feeling abnormal—Progesterone—uterine cancer	0.00033	0.00243	CcSEcCtD
Dexrazoxane—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000328	0.00242	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Progesterone—uterine cancer	0.000328	0.00241	CcSEcCtD
Dexrazoxane—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000324	0.00238	CcSEcCtD
Dexrazoxane—Pneumonia—Etoposide—uterine cancer	0.000323	0.00238	CcSEcCtD
Dexrazoxane—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000323	0.00237	CcSEcCtD
Dexrazoxane—Phosphatase alkaline increased—Epirubicin—uterine cancer	0.000322	0.00237	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Dactinomycin—uterine cancer	0.000322	0.00237	CcSEcCtD
Dexrazoxane—Infestation—Etoposide—uterine cancer	0.000321	0.00236	CcSEcCtD
Dexrazoxane—Infestation NOS—Etoposide—uterine cancer	0.000321	0.00236	CcSEcCtD
Dexrazoxane—Anaemia—Dactinomycin—uterine cancer	0.000321	0.00236	CcSEcCtD
Dexrazoxane—Injection site reaction—Epirubicin—uterine cancer	0.00032	0.00236	CcSEcCtD
Dexrazoxane—Urticaria—Progesterone—uterine cancer	0.000318	0.00234	CcSEcCtD
Dexrazoxane—Body temperature increased—Progesterone—uterine cancer	0.000317	0.00233	CcSEcCtD
Dexrazoxane—Abdominal pain—Progesterone—uterine cancer	0.000317	0.00233	CcSEcCtD
Dexrazoxane—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000315	0.00232	CcSEcCtD
Dexrazoxane—Blood bilirubin increased—Doxorubicin—uterine cancer	0.000315	0.00232	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000313	0.00231	CcSEcCtD
Dexrazoxane—Stomatitis—Etoposide—uterine cancer	0.000313	0.0023	CcSEcCtD
Dexrazoxane—Creatinine increased—Doxorubicin—uterine cancer	0.000313	0.0023	CcSEcCtD
Dexrazoxane—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000313	0.0023	CcSEcCtD
Dexrazoxane—Malaise—Dactinomycin—uterine cancer	0.000313	0.0023	CcSEcCtD
Dexrazoxane—Leukopenia—Dactinomycin—uterine cancer	0.00031	0.00229	CcSEcCtD
Dexrazoxane—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00031	0.00228	CcSEcCtD
Dexrazoxane—TOP2A—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.000305	0.0601	CbGdCrCtD
Dexrazoxane—Agranulocytosis—Etoposide—uterine cancer	0.0003	0.00221	CcSEcCtD
Dexrazoxane—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000299	0.0022	CcSEcCtD
Dexrazoxane—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.000298	0.00219	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000297	0.00218	CcSEcCtD
Dexrazoxane—Injection site reaction—Doxorubicin—uterine cancer	0.000296	0.00218	CcSEcCtD
Dexrazoxane—Myalgia—Dactinomycin—uterine cancer	0.000295	0.00217	CcSEcCtD
Dexrazoxane—Oesophagitis—Epirubicin—uterine cancer	0.000294	0.00216	CcSEcCtD
Dexrazoxane—Discomfort—Dactinomycin—uterine cancer	0.000292	0.00215	CcSEcCtD
Dexrazoxane—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000288	0.00212	CcSEcCtD
Dexrazoxane—Asthenia—Progesterone—uterine cancer	0.000287	0.00211	CcSEcCtD
Dexrazoxane—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000287	0.00211	CcSEcCtD
Dexrazoxane—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000287	0.00211	CcSEcCtD
Dexrazoxane—Pruritus—Progesterone—uterine cancer	0.000283	0.00209	CcSEcCtD
Dexrazoxane—Infection—Dactinomycin—uterine cancer	0.000281	0.00207	CcSEcCtD
Dexrazoxane—Sepsis—Epirubicin—uterine cancer	0.000279	0.00206	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Dactinomycin—uterine cancer	0.000277	0.00204	CcSEcCtD
Dexrazoxane—Diarrhoea—Progesterone—uterine cancer	0.000274	0.00202	CcSEcCtD
Dexrazoxane—Oesophagitis—Doxorubicin—uterine cancer	0.000272	0.002	CcSEcCtD
Dexrazoxane—Phlebitis—Epirubicin—uterine cancer	0.000271	0.002	CcSEcCtD
Dexrazoxane—Anorexia—Dactinomycin—uterine cancer	0.00027	0.00199	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000269	0.00198	CcSEcCtD
Dexrazoxane—Cardiac disorder—Etoposide—uterine cancer	0.000268	0.00197	CcSEcCtD
Dexrazoxane—TOP2A—Methyltestosterone—Progesterone—uterine cancer	0.000266	0.0524	CbGdCrCtD
Dexrazoxane—Dizziness—Progesterone—uterine cancer	0.000265	0.00195	CcSEcCtD
Dexrazoxane—Angiopathy—Etoposide—uterine cancer	0.000262	0.00193	CcSEcCtD
Dexrazoxane—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00026	0.00192	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Etoposide—uterine cancer	0.00026	0.00191	CcSEcCtD
Dexrazoxane—Sepsis—Doxorubicin—uterine cancer	0.000258	0.0019	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000258	0.0019	CcSEcCtD
Dexrazoxane—Cardiac failure congestive—Epirubicin—uterine cancer	0.000258	0.0019	CcSEcCtD
Dexrazoxane—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000257	0.00189	CcSEcCtD
Dexrazoxane—Alopecia—Etoposide—uterine cancer	0.000255	0.00188	CcSEcCtD
Dexrazoxane—Vomiting—Progesterone—uterine cancer	0.000255	0.00187	CcSEcCtD
Dexrazoxane—Phlebitis—Doxorubicin—uterine cancer	0.000251	0.00185	CcSEcCtD
Dexrazoxane—Headache—Progesterone—uterine cancer	0.000251	0.00185	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000249	0.00183	CcSEcCtD
Dexrazoxane—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000248	0.00183	CcSEcCtD
Dexrazoxane—Decreased appetite—Dactinomycin—uterine cancer	0.000246	0.00181	CcSEcCtD
Dexrazoxane—Fatigue—Dactinomycin—uterine cancer	0.000244	0.0018	CcSEcCtD
Dexrazoxane—Pain—Dactinomycin—uterine cancer	0.000242	0.00178	CcSEcCtD
Dexrazoxane—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00024	0.00177	CcSEcCtD
Dexrazoxane—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000238	0.00175	CcSEcCtD
Dexrazoxane—Nausea—Progesterone—uterine cancer	0.000238	0.00175	CcSEcCtD
Dexrazoxane—Hyponatraemia—Epirubicin—uterine cancer	0.000235	0.00173	CcSEcCtD
Dexrazoxane—Feeling abnormal—Dactinomycin—uterine cancer	0.000233	0.00172	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Etoposide—uterine cancer	0.000233	0.00171	CcSEcCtD
Dexrazoxane—Anaemia—Etoposide—uterine cancer	0.000232	0.00171	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000231	0.0017	CcSEcCtD
Dexrazoxane—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000231	0.0017	CcSEcCtD
Dexrazoxane—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000227	0.00167	CcSEcCtD
Dexrazoxane—Malaise—Etoposide—uterine cancer	0.000226	0.00167	CcSEcCtD
Dexrazoxane—Leukopenia—Etoposide—uterine cancer	0.000225	0.00165	CcSEcCtD
Dexrazoxane—Body temperature increased—Dactinomycin—uterine cancer	0.000224	0.00165	CcSEcCtD
Dexrazoxane—Abdominal pain—Dactinomycin—uterine cancer	0.000224	0.00165	CcSEcCtD
Dexrazoxane—Loss of consciousness—Etoposide—uterine cancer	0.000221	0.00162	CcSEcCtD
Dexrazoxane—Cough—Etoposide—uterine cancer	0.000219	0.00161	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Epirubicin—uterine cancer	0.000219	0.00161	CcSEcCtD
Dexrazoxane—Hyponatraemia—Doxorubicin—uterine cancer	0.000217	0.0016	CcSEcCtD
Dexrazoxane—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000216	0.00159	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000212	0.00156	CcSEcCtD
Dexrazoxane—Discomfort—Etoposide—uterine cancer	0.000211	0.00155	CcSEcCtD
Dexrazoxane—Breast disorder—Epirubicin—uterine cancer	0.000211	0.00155	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00021	0.00155	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000206	0.00152	CcSEcCtD
Dexrazoxane—Infection—Etoposide—uterine cancer	0.000204	0.0015	CcSEcCtD
Dexrazoxane—Asthenia—Dactinomycin—uterine cancer	0.000203	0.00149	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Doxorubicin—uterine cancer	0.000203	0.00149	CcSEcCtD
Dexrazoxane—Dysphagia—Epirubicin—uterine cancer	0.000202	0.00149	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Etoposide—uterine cancer	0.000201	0.00148	CcSEcCtD
Dexrazoxane—Skin disorder—Etoposide—uterine cancer	0.000199	0.00146	CcSEcCtD
Dexrazoxane—Breast disorder—Doxorubicin—uterine cancer	0.000195	0.00144	CcSEcCtD
Dexrazoxane—Anorexia—Etoposide—uterine cancer	0.000195	0.00144	CcSEcCtD
Dexrazoxane—TOP2A—Idarubicin—Epirubicin—uterine cancer	0.000195	0.0385	CbGdCrCtD
Dexrazoxane—TOP2A—Daunorubicin—Epirubicin—uterine cancer	0.000195	0.0385	CbGdCrCtD
Dexrazoxane—TOP2A—Doxorubicin—Epirubicin—uterine cancer	0.000195	0.0385	CbGdCrCtD
Dexrazoxane—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000195	0.00143	CcSEcCtD
Dexrazoxane—Diarrhoea—Dactinomycin—uterine cancer	0.000194	0.00143	CcSEcCtD
Dexrazoxane—Pancytopenia—Epirubicin—uterine cancer	0.000192	0.00141	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000191	0.0014	CcSEcCtD
Dexrazoxane—Neutropenia—Epirubicin—uterine cancer	0.000189	0.00139	CcSEcCtD
Dexrazoxane—Dysphagia—Doxorubicin—uterine cancer	0.000187	0.00138	CcSEcCtD
Dexrazoxane—Weight decreased—Epirubicin—uterine cancer	0.000183	0.00134	CcSEcCtD
Dexrazoxane—Dyspnoea—Etoposide—uterine cancer	0.000183	0.00134	CcSEcCtD
Dexrazoxane—Somnolence—Etoposide—uterine cancer	0.000182	0.00134	CcSEcCtD
Dexrazoxane—Pneumonia—Epirubicin—uterine cancer	0.000181	0.00133	CcSEcCtD
Dexrazoxane—TOP2A—Epirubicin—Doxorubicin—uterine cancer	0.000181	0.0356	CbGdCrCtD
Dexrazoxane—TOP2A—Daunorubicin—Doxorubicin—uterine cancer	0.000181	0.0356	CbGdCrCtD
Dexrazoxane—TOP2A—Idarubicin—Doxorubicin—uterine cancer	0.000181	0.0356	CbGdCrCtD
Dexrazoxane—Infestation—Epirubicin—uterine cancer	0.00018	0.00133	CcSEcCtD
Dexrazoxane—Infestation NOS—Epirubicin—uterine cancer	0.00018	0.00133	CcSEcCtD
Dexrazoxane—Vomiting—Dactinomycin—uterine cancer	0.00018	0.00132	CcSEcCtD
Dexrazoxane—Decreased appetite—Etoposide—uterine cancer	0.000178	0.00131	CcSEcCtD
Dexrazoxane—Pancytopenia—Doxorubicin—uterine cancer	0.000177	0.00131	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Etoposide—uterine cancer	0.000177	0.0013	CcSEcCtD
Dexrazoxane—Fatigue—Etoposide—uterine cancer	0.000177	0.0013	CcSEcCtD
Dexrazoxane—Stomatitis—Epirubicin—uterine cancer	0.000176	0.00129	CcSEcCtD
Dexrazoxane—Pain—Etoposide—uterine cancer	0.000175	0.00129	CcSEcCtD
Dexrazoxane—Constipation—Etoposide—uterine cancer	0.000175	0.00129	CcSEcCtD
Dexrazoxane—Neutropenia—Doxorubicin—uterine cancer	0.000175	0.00129	CcSEcCtD
Dexrazoxane—TOP2A—Norethindrone—Progesterone—uterine cancer	0.000174	0.0342	CbGdCrCtD
Dexrazoxane—Weight decreased—Doxorubicin—uterine cancer	0.000169	0.00124	CcSEcCtD
Dexrazoxane—Feeling abnormal—Etoposide—uterine cancer	0.000169	0.00124	CcSEcCtD
Dexrazoxane—Nausea—Dactinomycin—uterine cancer	0.000168	0.00124	CcSEcCtD
Dexrazoxane—Agranulocytosis—Epirubicin—uterine cancer	0.000168	0.00124	CcSEcCtD
Dexrazoxane—Pneumonia—Doxorubicin—uterine cancer	0.000168	0.00123	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Etoposide—uterine cancer	0.000168	0.00123	CcSEcCtD
Dexrazoxane—Infestation—Doxorubicin—uterine cancer	0.000167	0.00123	CcSEcCtD
Dexrazoxane—Infestation NOS—Doxorubicin—uterine cancer	0.000167	0.00123	CcSEcCtD
Dexrazoxane—Urticaria—Etoposide—uterine cancer	0.000163	0.0012	CcSEcCtD
Dexrazoxane—Haemoglobin—Epirubicin—uterine cancer	0.000162	0.0012	CcSEcCtD
Dexrazoxane—Stomatitis—Doxorubicin—uterine cancer	0.000162	0.0012	CcSEcCtD
Dexrazoxane—Abdominal pain—Etoposide—uterine cancer	0.000162	0.00119	CcSEcCtD
Dexrazoxane—Body temperature increased—Etoposide—uterine cancer	0.000162	0.00119	CcSEcCtD
Dexrazoxane—Haemorrhage—Epirubicin—uterine cancer	0.000162	0.00119	CcSEcCtD
Dexrazoxane—Oedema peripheral—Epirubicin—uterine cancer	0.000159	0.00117	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Epirubicin—uterine cancer	0.000159	0.00117	CcSEcCtD
Dexrazoxane—Agranulocytosis—Doxorubicin—uterine cancer	0.000155	0.00114	CcSEcCtD
Dexrazoxane—Haemoglobin—Doxorubicin—uterine cancer	0.00015	0.00111	CcSEcCtD
Dexrazoxane—Cardiac disorder—Epirubicin—uterine cancer	0.00015	0.0011	CcSEcCtD
Dexrazoxane—Haemorrhage—Doxorubicin—uterine cancer	0.00015	0.0011	CcSEcCtD
Dexrazoxane—Oedema peripheral—Doxorubicin—uterine cancer	0.000147	0.00108	CcSEcCtD
Dexrazoxane—Asthenia—Etoposide—uterine cancer	0.000147	0.00108	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Doxorubicin—uterine cancer	0.000147	0.00108	CcSEcCtD
Dexrazoxane—Angiopathy—Epirubicin—uterine cancer	0.000147	0.00108	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Epirubicin—uterine cancer	0.000146	0.00107	CcSEcCtD
Dexrazoxane—Pruritus—Etoposide—uterine cancer	0.000145	0.00107	CcSEcCtD
Dexrazoxane—Alopecia—Epirubicin—uterine cancer	0.000143	0.00105	CcSEcCtD
Dexrazoxane—Mental disorder—Epirubicin—uterine cancer	0.000142	0.00104	CcSEcCtD
Dexrazoxane—Erythema—Epirubicin—uterine cancer	0.000141	0.00104	CcSEcCtD
Dexrazoxane—Malnutrition—Epirubicin—uterine cancer	0.000141	0.00104	CcSEcCtD
Dexrazoxane—Diarrhoea—Etoposide—uterine cancer	0.00014	0.00103	CcSEcCtD
Dexrazoxane—Cardiac disorder—Doxorubicin—uterine cancer	0.000139	0.00102	CcSEcCtD
Dexrazoxane—TOP2A—Levonorgestrel—Progesterone—uterine cancer	0.000138	0.0272	CbGdCrCtD
Dexrazoxane—Angiopathy—Doxorubicin—uterine cancer	0.000136	0.000999	CcSEcCtD
Dexrazoxane—Dizziness—Etoposide—uterine cancer	0.000135	0.000997	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Doxorubicin—uterine cancer	0.000135	0.000992	CcSEcCtD
Dexrazoxane—Alopecia—Doxorubicin—uterine cancer	0.000132	0.000973	CcSEcCtD
Dexrazoxane—Mental disorder—Doxorubicin—uterine cancer	0.000131	0.000964	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Epirubicin—uterine cancer	0.000131	0.000961	CcSEcCtD
Dexrazoxane—Vomiting—Etoposide—uterine cancer	0.00013	0.000959	CcSEcCtD
Dexrazoxane—Erythema—Doxorubicin—uterine cancer	0.00013	0.000958	CcSEcCtD
Dexrazoxane—Malnutrition—Doxorubicin—uterine cancer	0.00013	0.000958	CcSEcCtD
Dexrazoxane—Anaemia—Epirubicin—uterine cancer	0.00013	0.000957	CcSEcCtD
Dexrazoxane—Headache—Etoposide—uterine cancer	0.000128	0.000945	CcSEcCtD
Dexrazoxane—Malaise—Epirubicin—uterine cancer	0.000127	0.000934	CcSEcCtD
Dexrazoxane—Syncope—Epirubicin—uterine cancer	0.000126	0.000929	CcSEcCtD
Dexrazoxane—Leukopenia—Epirubicin—uterine cancer	0.000126	0.000927	CcSEcCtD
Dexrazoxane—Loss of consciousness—Epirubicin—uterine cancer	0.000124	0.00091	CcSEcCtD
Dexrazoxane—Cough—Epirubicin—uterine cancer	0.000123	0.000904	CcSEcCtD
Dexrazoxane—Nausea—Etoposide—uterine cancer	0.000122	0.000896	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Doxorubicin—uterine cancer	0.000121	0.000889	CcSEcCtD
Dexrazoxane—Anaemia—Doxorubicin—uterine cancer	0.00012	0.000886	CcSEcCtD
Dexrazoxane—Myalgia—Epirubicin—uterine cancer	0.00012	0.000882	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000119	0.000876	CcSEcCtD
Dexrazoxane—Discomfort—Epirubicin—uterine cancer	0.000118	0.000871	CcSEcCtD
Dexrazoxane—Malaise—Doxorubicin—uterine cancer	0.000117	0.000864	CcSEcCtD
Dexrazoxane—Dry mouth—Epirubicin—uterine cancer	0.000117	0.000862	CcSEcCtD
Dexrazoxane—Syncope—Doxorubicin—uterine cancer	0.000117	0.000859	CcSEcCtD
Dexrazoxane—Leukopenia—Doxorubicin—uterine cancer	0.000117	0.000858	CcSEcCtD
Dexrazoxane—Loss of consciousness—Doxorubicin—uterine cancer	0.000114	0.000842	CcSEcCtD
Dexrazoxane—Infection—Epirubicin—uterine cancer	0.000114	0.00084	CcSEcCtD
Dexrazoxane—Cough—Doxorubicin—uterine cancer	0.000114	0.000836	CcSEcCtD
Dexrazoxane—Shock—Epirubicin—uterine cancer	0.000113	0.000832	CcSEcCtD
Dexrazoxane—Nervous system disorder—Epirubicin—uterine cancer	0.000113	0.000829	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Epirubicin—uterine cancer	0.000112	0.000828	CcSEcCtD
Dexrazoxane—Skin disorder—Epirubicin—uterine cancer	0.000112	0.000821	CcSEcCtD
Dexrazoxane—Myalgia—Doxorubicin—uterine cancer	0.000111	0.000816	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00011	0.00081	CcSEcCtD
Dexrazoxane—Discomfort—Doxorubicin—uterine cancer	0.00011	0.000806	CcSEcCtD
Dexrazoxane—Anorexia—Epirubicin—uterine cancer	0.000109	0.000806	CcSEcCtD
Dexrazoxane—Dry mouth—Doxorubicin—uterine cancer	0.000108	0.000798	CcSEcCtD
Dexrazoxane—Infection—Doxorubicin—uterine cancer	0.000106	0.000777	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000105	0.00077	CcSEcCtD
Dexrazoxane—Shock—Doxorubicin—uterine cancer	0.000105	0.000769	CcSEcCtD
Dexrazoxane—Nervous system disorder—Doxorubicin—uterine cancer	0.000104	0.000767	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Doxorubicin—uterine cancer	0.000104	0.000766	CcSEcCtD
Dexrazoxane—Insomnia—Epirubicin—uterine cancer	0.000104	0.000764	CcSEcCtD
Dexrazoxane—Skin disorder—Doxorubicin—uterine cancer	0.000103	0.00076	CcSEcCtD
Dexrazoxane—Dyspnoea—Epirubicin—uterine cancer	0.000102	0.000754	CcSEcCtD
Dexrazoxane—Somnolence—Epirubicin—uterine cancer	0.000102	0.000751	CcSEcCtD
Dexrazoxane—Anorexia—Doxorubicin—uterine cancer	0.000101	0.000745	CcSEcCtD
Dexrazoxane—Decreased appetite—Epirubicin—uterine cancer	9.98e-05	0.000735	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Epirubicin—uterine cancer	9.92e-05	0.00073	CcSEcCtD
Dexrazoxane—Fatigue—Epirubicin—uterine cancer	9.9e-05	0.000729	CcSEcCtD
Dexrazoxane—Pain—Epirubicin—uterine cancer	9.82e-05	0.000723	CcSEcCtD
Dexrazoxane—Constipation—Epirubicin—uterine cancer	9.82e-05	0.000723	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Doxorubicin—uterine cancer	9.68e-05	0.000713	CcSEcCtD
Dexrazoxane—Insomnia—Doxorubicin—uterine cancer	9.61e-05	0.000707	CcSEcCtD
Dexrazoxane—Dyspnoea—Doxorubicin—uterine cancer	9.47e-05	0.000697	CcSEcCtD
Dexrazoxane—Feeling abnormal—Epirubicin—uterine cancer	9.46e-05	0.000697	CcSEcCtD
Dexrazoxane—Somnolence—Doxorubicin—uterine cancer	9.45e-05	0.000695	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Epirubicin—uterine cancer	9.39e-05	0.000691	CcSEcCtD
Dexrazoxane—Decreased appetite—Doxorubicin—uterine cancer	9.24e-05	0.00068	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Doxorubicin—uterine cancer	9.17e-05	0.000675	CcSEcCtD
Dexrazoxane—Fatigue—Doxorubicin—uterine cancer	9.16e-05	0.000674	CcSEcCtD
Dexrazoxane—Urticaria—Epirubicin—uterine cancer	9.12e-05	0.000671	CcSEcCtD
Dexrazoxane—Constipation—Doxorubicin—uterine cancer	9.09e-05	0.000669	CcSEcCtD
Dexrazoxane—Pain—Doxorubicin—uterine cancer	9.09e-05	0.000669	CcSEcCtD
Dexrazoxane—Body temperature increased—Epirubicin—uterine cancer	9.08e-05	0.000668	CcSEcCtD
Dexrazoxane—Abdominal pain—Epirubicin—uterine cancer	9.08e-05	0.000668	CcSEcCtD
Dexrazoxane—Feeling abnormal—Doxorubicin—uterine cancer	8.76e-05	0.000644	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Doxorubicin—uterine cancer	8.69e-05	0.00064	CcSEcCtD
Dexrazoxane—Urticaria—Doxorubicin—uterine cancer	8.44e-05	0.000621	CcSEcCtD
Dexrazoxane—Abdominal pain—Doxorubicin—uterine cancer	8.4e-05	0.000618	CcSEcCtD
Dexrazoxane—Body temperature increased—Doxorubicin—uterine cancer	8.4e-05	0.000618	CcSEcCtD
Dexrazoxane—Asthenia—Epirubicin—uterine cancer	8.24e-05	0.000606	CcSEcCtD
Dexrazoxane—Pruritus—Epirubicin—uterine cancer	8.13e-05	0.000598	CcSEcCtD
Dexrazoxane—Diarrhoea—Epirubicin—uterine cancer	7.86e-05	0.000578	CcSEcCtD
Dexrazoxane—Asthenia—Doxorubicin—uterine cancer	7.62e-05	0.000561	CcSEcCtD
Dexrazoxane—Dizziness—Epirubicin—uterine cancer	7.59e-05	0.000559	CcSEcCtD
Dexrazoxane—Pruritus—Doxorubicin—uterine cancer	7.52e-05	0.000553	CcSEcCtD
Dexrazoxane—Vomiting—Epirubicin—uterine cancer	7.3e-05	0.000537	CcSEcCtD
Dexrazoxane—Diarrhoea—Doxorubicin—uterine cancer	7.27e-05	0.000535	CcSEcCtD
Dexrazoxane—Headache—Epirubicin—uterine cancer	7.19e-05	0.00053	CcSEcCtD
Dexrazoxane—Dizziness—Doxorubicin—uterine cancer	7.03e-05	0.000517	CcSEcCtD
Dexrazoxane—Nausea—Epirubicin—uterine cancer	6.82e-05	0.000502	CcSEcCtD
Dexrazoxane—Vomiting—Doxorubicin—uterine cancer	6.76e-05	0.000497	CcSEcCtD
Dexrazoxane—Headache—Doxorubicin—uterine cancer	6.66e-05	0.00049	CcSEcCtD
Dexrazoxane—Nausea—Doxorubicin—uterine cancer	6.31e-05	0.000465	CcSEcCtD
